RADICAVA

Serial Number 87132086
Registration 5387607
702

Registration Progress

Application Filed
Aug 9, 2016
Under Examination
Dec 27, 2016
Approved for Publication
Nov 1, 2016
Published for Opposition
Nov 1, 2016
Registered
Jan 23, 2018

Trademark Image

RADICAVA

Basic Information

Serial Number
87132086
Registration Number
5387607
Filing Date
August 9, 2016
Registration Date
January 23, 2018
Published for Opposition
November 1, 2016
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Aug 8, 2024
Registration
Registered
Classes
005

Rights Holder

Mitsubishi Tanabe Pharma Corporation

03
Address
3-2-10, Dosho-machi, Chuo-ku, Osaka-shi
Osaka 541-8505
JP

Ownership History

Mitsubishi Tanabe Pharma Corporation

Original Applicant
03
Osaka JP

Mitsubishi Tanabe Pharma Corporation

Owner at Publication
03
Osaka JP

Mitsubishi Tanabe Pharma Corporation

Original Registrant
03
Osaka JP

Legal Representation

Attorney
Jeffrey L. Costellia

USPTO Deadlines

Next Deadline
920 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-01-23)
Due Date
January 23, 2028
Grace Period Ends
July 23, 2028

Application History

35 events
Date Code Type Description Documents
Aug 8, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Aug 8, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Aug 6, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 19, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 23, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 23, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 21, 2017 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 20, 2017 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 12, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 11, 2017 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 11, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 11, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 7, 2017 IUAF S USE AMENDMENT FILED Loading...
Dec 7, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 7, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 7, 2017 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 24, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 22, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 22, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 22, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 27, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 1, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 1, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 12, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 27, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 27, 2016 ALIE A ASSIGNED TO LIE Loading...
Sep 14, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 30, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 30, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 30, 2016 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 30, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 29, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 13, 2016 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 12, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 12, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
First Use Anywhere: Jul 18, 2017
First Use in Commerce: Jul 18, 2017

Additional Information

Design Mark
The mark consists of the stylized term "RADICAVA" above six curved lines each formed by dots and each of increasing lengths.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005